Cargando…

Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan

BACKGROUND: Standardization of quality of life (QOL) assessment and reporting in clinical trials is an imperative issue. While English-speaking countries have led this movement in standardization, there persists to be a limited amount of information from non-English-speaking including Japan. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Naito, Mariko, Nakayama, Takeo, Fukuhara, Shunichi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC449732/
https://www.ncbi.nlm.nih.gov/pubmed/15217517
http://dx.doi.org/10.1186/1477-7525-2-31
_version_ 1782121575694204928
author Naito, Mariko
Nakayama, Takeo
Fukuhara, Shunichi
author_facet Naito, Mariko
Nakayama, Takeo
Fukuhara, Shunichi
author_sort Naito, Mariko
collection PubMed
description BACKGROUND: Standardization of quality of life (QOL) assessment and reporting in clinical trials is an imperative issue. While English-speaking countries have led this movement in standardization, there persists to be a limited amount of information from non-English-speaking including Japan. In this study, we bibliographically analyze the reporting of randomized controlled trials (RCT) conducted in Japan that used a QOL instrument. METHODS: A PubMed search of reports published between 1970–2003 followed by an examination of QOL reporting and its frequency of use in RCTs published from Japan. RESULTS: Percentages of QOL reporting in RCTs have increased between 1970–2003 both worldwide (0% for 1970–1974 to 4.4% for 2000–2003) and in Japan (0% to 1.8% for the identical periods). We found and evaluated 46 RCT reports published from Japan (32 in English, 14 in Japanese). The most commonly studied clinical condition was cancer (26, 56.5%) and the most common intervention was drug therapy (29, 63.0%). QOL was used as the primary endpoint in 10 studies (21.7%). Authors used established QOL instruments in 12 studies (26.1%), developed original instruments in 8 studies (17.5%) and assessed the symptoms or performance status in 10 studies (21.7%). Authors conceptually defined QOL in only 6 studies (13.0%). Neither response rate nor number of respondents for questionnaire surveys was specified in 16 studies (34.8%); furthermore, 11 studies (23.9%) did not describe respondents' attributes. CONCLUSIONS: Findings on relative frequency suggested that Japanese authors of RCT reports have less interest in QOL instruments than other international researchers in Western Europe and North America. Examination of RCT reports published from Japan revealed that there were several points to be improved in reporting QOL instruments. This study highlights the need to define QOL measures specific to clinical specialty and to examine methodology for assessing and reporting QOL.
format Text
id pubmed-449732
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4497322004-07-10 Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan Naito, Mariko Nakayama, Takeo Fukuhara, Shunichi Health Qual Life Outcomes Review BACKGROUND: Standardization of quality of life (QOL) assessment and reporting in clinical trials is an imperative issue. While English-speaking countries have led this movement in standardization, there persists to be a limited amount of information from non-English-speaking including Japan. In this study, we bibliographically analyze the reporting of randomized controlled trials (RCT) conducted in Japan that used a QOL instrument. METHODS: A PubMed search of reports published between 1970–2003 followed by an examination of QOL reporting and its frequency of use in RCTs published from Japan. RESULTS: Percentages of QOL reporting in RCTs have increased between 1970–2003 both worldwide (0% for 1970–1974 to 4.4% for 2000–2003) and in Japan (0% to 1.8% for the identical periods). We found and evaluated 46 RCT reports published from Japan (32 in English, 14 in Japanese). The most commonly studied clinical condition was cancer (26, 56.5%) and the most common intervention was drug therapy (29, 63.0%). QOL was used as the primary endpoint in 10 studies (21.7%). Authors used established QOL instruments in 12 studies (26.1%), developed original instruments in 8 studies (17.5%) and assessed the symptoms or performance status in 10 studies (21.7%). Authors conceptually defined QOL in only 6 studies (13.0%). Neither response rate nor number of respondents for questionnaire surveys was specified in 16 studies (34.8%); furthermore, 11 studies (23.9%) did not describe respondents' attributes. CONCLUSIONS: Findings on relative frequency suggested that Japanese authors of RCT reports have less interest in QOL instruments than other international researchers in Western Europe and North America. Examination of RCT reports published from Japan revealed that there were several points to be improved in reporting QOL instruments. This study highlights the need to define QOL measures specific to clinical specialty and to examine methodology for assessing and reporting QOL. BioMed Central 2004-06-25 /pmc/articles/PMC449732/ /pubmed/15217517 http://dx.doi.org/10.1186/1477-7525-2-31 Text en Copyright © 2004 Naito et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Review
Naito, Mariko
Nakayama, Takeo
Fukuhara, Shunichi
Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan
title Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan
title_full Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan
title_fullStr Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan
title_full_unstemmed Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan
title_short Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan
title_sort quality of life assessment and reporting in randomized controlled trials: a study of literature published from japan
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC449732/
https://www.ncbi.nlm.nih.gov/pubmed/15217517
http://dx.doi.org/10.1186/1477-7525-2-31
work_keys_str_mv AT naitomariko qualityoflifeassessmentandreportinginrandomizedcontrolledtrialsastudyofliteraturepublishedfromjapan
AT nakayamatakeo qualityoflifeassessmentandreportinginrandomizedcontrolledtrialsastudyofliteraturepublishedfromjapan
AT fukuharashunichi qualityoflifeassessmentandreportinginrandomizedcontrolledtrialsastudyofliteraturepublishedfromjapan